Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126813623 | 12681362 | 3 | F | 20160310 | 20160513 | 20160824 | 20160902 | EXP | FR-PFIZER INC-2016390035 | PFIZER | 69.00 | YR | M | Y | 0.00000 | 20160902 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126813623 | 12681362 | 1 | PS | Amlor | AMLODIPINE BESYLATE | 1 | Oral | 1 DF, DAILY | 65 | MG | Y | 19787 | 1 | DF | CAPSULE, HARD | ||||
126813623 | 12681362 | 2 | SS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | UNK | Y | 20702 | |||||||||
126813623 | 12681362 | 3 | SS | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | Oral | UNK | Y | 18972 | TABLET | ||||||||
126813623 | 12681362 | 4 | SS | ZYDELIG | IDELALISIB | 1 | Oral | 2 DF, DAILY | 8700 | MG | Y | 0 | 2 | DF | FILM-COATED TABLET | ||||
126813623 | 12681362 | 5 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | UNK | Y | 0 | TABLET | ||||||||
126813623 | 12681362 | 6 | SS | ZELITREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 1 DF, UNK | 0 | 1 | DF | COATED TABLET | |||||||
126813623 | 12681362 | 7 | SS | CALCIPARINE | HEPARIN CALCIUM | 1 | UNK | Y | 0 | ||||||||||
126813623 | 12681362 | 8 | SS | LOXEN L P | NICARDIPINE HYDROCHLORIDE | 1 | Oral | 2 DF, 2X/DAY | Y | 0 | 2 | DF | PROLONGED-RELEASE CAPSULE | BID | |||||
126813623 | 12681362 | 9 | SS | LASILIX RETARD | FUROSEMIDE | 1 | Oral | 60 MG, UNK | Y | 0 | 60 | MG | CAPSULE | ||||||
126813623 | 12681362 | 10 | SS | LASILIX /00032601/ | FUROSEMIDE | 1 | Oral | UNK | Y | 0 | |||||||||
126813623 | 12681362 | 11 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | UNK | 0 | |||||||||||
126813623 | 12681362 | 12 | C | EUPANTOL | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
126813623 | 12681362 | 13 | C | DUPHALAC | LACTULOSE | 1 | UNK | 0 | |||||||||||
126813623 | 12681362 | 14 | C | ATROVENT | IPRATROPIUM BROMIDE | 1 | UNK | 0 | |||||||||||
126813623 | 12681362 | 15 | C | VENTOLINE /00139501/ | ALBUTEROL | 1 | UNK | 0 | |||||||||||
126813623 | 12681362 | 16 | C | TRIATEC /00885601/ | RAMIPRIL | 1 | 1.25 MG, UNK | 0 | 1.25 | MG | |||||||||
126813623 | 12681362 | 17 | C | PENTACARINAT | PENTAMIDINE ISETHIONATE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126813623 | 12681362 | 1 | Hypertension |
126813623 | 12681362 | 4 | Waldenstrom's macroglobulinaemia |
126813623 | 12681362 | 7 | Face oedema |
126813623 | 12681362 | 8 | Hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126813623 | 12681362 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126813623 | 12681362 | Dermatitis exfoliative |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126813623 | 12681362 | 1 | 20160227 | 20160411 | 0 | |
126813623 | 12681362 | 2 | 20160201 | 20160422 | 0 | |
126813623 | 12681362 | 3 | 20160524 | 0 | ||
126813623 | 12681362 | 4 | 20160211 | 20160603 | 0 | |
126813623 | 12681362 | 5 | 20160211 | 20160218 | 0 | |
126813623 | 12681362 | 6 | 20160211 | 0 | ||
126813623 | 12681362 | 7 | 20160227 | 20160411 | 0 | |
126813623 | 12681362 | 8 | 20160422 | 20160603 | 0 | |
126813623 | 12681362 | 9 | 20160411 | 0 | ||
126813623 | 12681362 | 10 | 20160211 | 20160531 | 0 | |
126813623 | 12681362 | 17 | 201603 | 0 |